While it was initially isolated from a breast cancer cell line, increased expression of ABCG2 has been identified in many cancers, including myeloma, glioblastoma, esophageal, tongue, and ovarian cancer [39,40]. This evidence concerns the gene ABCG2 and ovarian cancer.